What are the criteria for high‑risk Kawasaki disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

High-Risk Kawasaki Disease Criteria

High-risk Kawasaki disease is identified using the Harada score, which predicts coronary artery aneurysm development when 4 or more of 7 specific criteria are met within 9 days of illness onset. 1

The Harada Score Criteria

The following 7 factors are assessed, with ≥4 factors indicating high risk for coronary artery abnormalities:

  1. White blood cell count ≥12,000/mm³
  2. Platelet count ≤350,000/mm³
  3. C-reactive protein ≥3 mg/dL
  4. Hematocrit ≤35%
  5. Albumin ≤3.5 g/dL
  6. Age ≤12 months
  7. Male sex

1

Additional High-Risk Clinical Features

Beyond the Harada score, several other factors independently predict severe coronary involvement:

Timing and Fever Duration

  • Fever duration >10 days (OR 3.23) 2
  • Delayed IVIG administration >10 days after fever onset (OR 2.50) 2
  • Prolonged fever before treatment 3

Laboratory Markers

  • WBC >20 × 10⁹/L (OR 1.73) 2
  • CRP >100 mg/L (OR 2.37) 2
  • Hypoalbuminemia (protective when higher) 3
  • Anemia and thrombocytosis 3
  • Very high platelet counts 4
  • High ESR 4

Cardiac Findings

  • Baseline pericardial effusion - independent predictor of severe disease 3
  • Coronary artery Z-score ≥5.0 - defines severe Kawasaki disease 3

Demographic Risk

  • Age <6 months - highest risk group 4
  • Age ≤1 year (OR 1.58) 2

North American Post-Treatment Risk Assessment

The Beiser instrument evaluates risk after IVIG treatment using:

  • Baseline neutrophil and band counts
  • Hemoglobin concentration
  • Platelet count
  • Temperature on the day after IVIG infusion

1

Critical Clinical Caveats

Important limitation: The Harada score was developed in Japan and has low sensitivity in North American populations 5. The Beiser instrument also has poor positive predictive value (only 13.8% in boys, 5.5% in girls classified as high-risk actually developed coronary abnormalities) 1.

Despite imperfect scoring systems, all patients diagnosed with Kawasaki disease should be treated with IVIG 1. The scoring systems are primarily useful for:

  • Identifying patients who may need intensified initial therapy (in Japan)
  • Determining frequency of cardiac monitoring
  • Research stratification

Duration of fever remains the most powerful predictor of coronary artery aneurysms across all studies, reflecting ongoing vasculitis severity 1.

High-Risk Management Implications

In Japan, high-risk patients (by Kobayashi, Egami, or Sano scores) receive intensified primary therapy with corticosteroids added to IVIG, which reduces coronary abnormalities 5. However, these Japanese prediction scores have not been validated for North American populations, and further research is needed to develop reliable predictive instruments outside Japan 5.

Persistent abnormalities occur in 60% of severe cases despite treatment, emphasizing the importance of early recognition 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.